A TOP2A‑derived cancer panel drives cancer progression in papillary renal cell carcinoma

  • Authors:
    • Mushi Ye
    • Zhuobin He
    • Wei Dai
    • Zhuo Li
    • Xiaojun Chen
    • Jianjun Liu
  • View Affiliations

  • Published online on: July 19, 2018     https://doi.org/10.3892/ol.2018.9179
  • Pages: 4169-4178
  • Copyright: © Ye et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the function of the DNA topoisomerase IIα (TOP2A) gene and its associated genes in the progression of papillary renal cell carcinoma (PRCC). Online cancer databases, including cBioportal, Oncomine, OncoLnc and Search Tool for the Retrieval of Interacting Genes/Proteins were used to analyze the TOP2A gene expression profile, function and regulation network in PRCC. The genes that were significantly co‑expressed or mutually exclusively expressed with TOP2A were identified. The genes co‑expressed with TOP2A were defined as a ‘TOP2A‑cancer panel’, which cooperatively promotes PRCC progression. This gene panel performed well in predicting the prognosis of PRCC. In addition, the TOP2A‑cancer panel significantly affected the outcome of PRCC compared with clear cell renal cell carcinoma (CCRCC). The protein‑protein interaction network of all genes associated with TOP2A was also generated. This interaction network may provide foundation for the additional investigation of TOP2A. Integrative understating of the TOP2A‑cancer panel may result in a novel avenue for treatment intervention in PRCC.
View Figures
View References

Related Articles

Journal Cover

October-2018
Volume 16 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ye M, He Z, Dai W, Li Z, Chen X and Liu J: A TOP2A‑derived cancer panel drives cancer progression in papillary renal cell carcinoma. Oncol Lett 16: 4169-4178, 2018
APA
Ye, M., He, Z., Dai, W., Li, Z., Chen, X., & Liu, J. (2018). A TOP2A‑derived cancer panel drives cancer progression in papillary renal cell carcinoma. Oncology Letters, 16, 4169-4178. https://doi.org/10.3892/ol.2018.9179
MLA
Ye, M., He, Z., Dai, W., Li, Z., Chen, X., Liu, J."A TOP2A‑derived cancer panel drives cancer progression in papillary renal cell carcinoma". Oncology Letters 16.4 (2018): 4169-4178.
Chicago
Ye, M., He, Z., Dai, W., Li, Z., Chen, X., Liu, J."A TOP2A‑derived cancer panel drives cancer progression in papillary renal cell carcinoma". Oncology Letters 16, no. 4 (2018): 4169-4178. https://doi.org/10.3892/ol.2018.9179